loading
Precedente Chiudi:
$1.91
Aprire:
$1.95
Volume 24 ore:
7,181
Relative Volume:
0.01
Capitalizzazione di mercato:
$4.45M
Reddito:
-
Utile/perdita netta:
$-4.69M
Rapporto P/E:
-0.5351
EPS:
-3.7
Flusso di cassa netto:
$-3.81M
1 W Prestazione:
-0.26%
1M Prestazione:
+32.89%
6M Prestazione:
-20.32%
1 anno Prestazione:
-5.71%
Intervallo 1D:
Value
$1.85
$2.14
Intervallo di 1 settimana:
Value
$1.80
$2.65
Portata 52W:
Value
$1.31
$4.40

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Name
Nome
Lixte Biotechnology Holdings Inc
Name
Telefono
310 203 2902
Name
Indirizzo
248 ROUTE 25A, EAST SETAUKET
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
LIXT's Discussions on Twitter

Confronta LIXT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LIXT
Lixte Biotechnology Holdings Inc
1.98 4.45M 0 -4.69M -3.81M -2.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie

pulisher
Dec 18, 2024

US Penny Stocks To Watch In December 2024 - Simply Wall St

Dec 18, 2024
pulisher
Dec 05, 2024

LIXT (Lixte Biotechnology Holdings) 3-Year Sharpe Ratio : -0.39 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 02, 2024

LIXTE Biotechnology inks amendment to cancer drug study agreement - Investing.com

Dec 02, 2024
pulisher
Dec 02, 2024

LIXTE Biotechnology inks amendment to cancer drug study agreement By Investing.com - Investing.com Nigeria

Dec 02, 2024
pulisher
Dec 02, 2024

Lixte Biotechnology Holdings, Inc. Enters into Development Collaboration Agreement with the Netherlands Cancer Institute, Amsterdam - Marketscreener.com

Dec 02, 2024
pulisher
Nov 23, 2024

Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 15, 2024

LIXTW (Lixte Biotechnology Holdings) Accounts Payable & Acc - GuruFocus.com

Nov 15, 2024
pulisher
Oct 29, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 29, 2024
pulisher
Oct 28, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com

Oct 23, 2024
pulisher
Oct 09, 2024

Lixte Biotechnology Holdings Inc WT (LIXTW-Q) QuotePress Release - The Globe and Mail

Oct 09, 2024
pulisher
Oct 01, 2024

Omeros (OMER) Shares Drop 5.04% Amid Financial Struggles - GuruFocus.com

Oct 01, 2024
pulisher
Oct 01, 2024

MRVI Stock Drops 5.11% Amid Financial Report Release - GuruFocus.com

Oct 01, 2024
pulisher
Sep 24, 2024

Lixte Biotechnology (NASDAQ:LIXT) Stock Price Down 2.1% - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy - GlobeNewswire

Sep 24, 2024
pulisher
Sep 23, 2024

Should investors be concerned about LYT’s high price-to-sales ratio? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Lilium (NASDAQ:LILM) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Pacer Advisors Inc. Has $16.07 Million Stock Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Renaissance Technologies LLC Sells 2,000 Shares of LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Texas Permanent School Fund Corp Trims Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

First Eagle Investment Management LLC Increases Stake in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Huber Capital Management LLC Acquires 241,814 Shares of Lyft, Inc. (NASDAQ:LYFT) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Acadian Asset Management LLC Cuts Position in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Quest Partners LLC Invests $28,000 in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Investors who lost money with shares of Liquidia Corporation - openPR

Sep 19, 2024
pulisher
Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - Kilgore News Herald

Sep 18, 2024
pulisher
Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024
pulisher
Sep 10, 2024

Biotech Steals The Show Following Pre-Clinical Data Announcement - MSN

Sep 10, 2024
pulisher
Sep 05, 2024

Lixte Biotechnology Holdings Inc (LIXT) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 05, 2024
pulisher
Sep 04, 2024

LIXTLixte Biotechnology Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology - GlobeNewswire

Sep 04, 2024
pulisher
Aug 31, 2024

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Update - Defense World

Aug 31, 2024
pulisher
Aug 28, 2024

Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 28, 2024
pulisher
Aug 27, 2024

Market Recap Check: Lixte Biotechnology Holdings Inc (LIXT)’s Positive Finish at 2.00, Up/Down 11.12 - The Dwinnex

Aug 27, 2024
pulisher
Aug 27, 2024

LIXT Stock: A Voyage Through Lixte Biotechnology Holdings Inc’s Finances - The InvestChronicle

Aug 27, 2024
pulisher
Aug 27, 2024

LIXT stock touches 52-week low at $1.55 amid market fluctuations - Investing.com

Aug 27, 2024
pulisher
Aug 26, 2024

First Patient Dosed with LIXTE’s LB-100 in New Clinical - GlobeNewswire

Aug 26, 2024
pulisher
Aug 26, 2024

First Patient Dosed with Lixte Biotechnology Holdings, Inc.?s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - Marketscreener.com

Aug 26, 2024
pulisher
Aug 26, 2024

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - StockTitan

Aug 26, 2024
pulisher
Aug 24, 2024

Lixte Biotechnology faces Nasdaq delisting over equity shortfall - Investing.com India

Aug 24, 2024
pulisher
Aug 20, 2024

LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 20, 2024) - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Inventory-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXTE Biotechnology Provides Update On Recent Activities and Developments - ForexTV.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Purchase Of Investment : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Owner Earnings per Shar - GuruFocus.com

Aug 19, 2024
pulisher
Aug 18, 2024

LIXT (Lixte Biotechnology Holdings) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024

Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):